Depletion of gut commensal bacteria attenuates intestinal ischemia/reperfusion injury

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 301, Issue 6, 2011, Pages

  Yoshiya, Kazuhisa ^a   Lapchak, Peter H ^a   Thai, To Ha ^a   Kannan, Lakshmi ^a   Rani, Poonam ^a   Lucca, Jurandir J Dalle ^b   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b U S ARMY   (United States)

Author keywords

Complement; Immunoglobulin A; Immunoglobulin M; Intestine

Indexed keywords

AMPICILLIN; COMPLEMENT COMPONENT C3; CYCLOOXYGENASE 2; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 6; MESSENGER RNA; METRONIDAZOLE; NEOMYCIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOCYTE; COMPLEMENT DEPOSITION; COMPLEMENT INHIBITION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IMMUNOGLOBULIN DEPOSITION; IMMUNOGLOBULIN PRODUCTION; INTESTINE FLORA; INTESTINE ISCHEMIA; MALE; MOUSE; NONHUMAN; ORGAN SIZE; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REPERFUSION INJURY;

ANIMALS; ANTI-BACTERIAL AGENTS; CECUM; COMPLEMENT SYSTEM PROTEINS; ENTERITIS; HOMEOSTASIS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTESTINES; LYMPHOID TISSUE; MALE; METAGENOME; MICE; MICE, INBRED C57BL; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 82455175817     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00239.2011     Document Type: Article

References (72)

1. Abreu M. Toll-like receptor signaling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10: 131-143, 2010.
2. Akira A, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 124: 783-801, 2006.
3. Aprahamian CJ, Lorenz RG, Harmon CM, Dimmit RA. Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model. Pediatr Crit Care Med 9: 105-109, 2008.
4. Arslan F, Keogh B, McGuirk P, Parker AE. TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm 2010: 704202, 2010.
5. Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM, Woodruff TM. Toll-like receptors in ischemia-reperfusion injury. Shock 32: 4-16, 2009.
6. Bach JF. The effect of infections on susceptibility to autoimmune and allergic disease. N Engl J Med 347: 911-920, 2002.
7. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza infection. J Exp Med 192: 271-280, 2000.
8. Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 26: 347-362, 2005.
9. Bianchi ME. DAMPS, PAMPS and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5, 2007.
10. Bouskra D, Brézillon C, Bérard M, Werts C, Varona R, Boneca IG, Eberl G. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456: 507-512, 2008.
11. Cebra JJ. Influence of microbiota on intestinal immune system development. Am J Clin Nutr 69: 1046S-1051S, 1999.
12. Cerutti A, Rescingo M. The biology of intestinal immunoglobulin A responses. Immunity 29: 740-750, 2008.
13. Chen J, Crispin JC, Dalle Lucca JJ, Tsokos GC. A novel inhibitor of the alternative pathway of complement attenuates intestinal ischemia/ reperfusion-induced injury. J Surg Res 167: e131-e136, 2011.
14. Chen J, Crispin JC, Tedder TF, Dalle Lucca JJ, Tsokos GC. B cells contribute to ischemia/reperfusion-mediated tissue injury. J Autoimmun 32: 195-200, 2009.
15. Chen LW, Chang WJ, Chen PH, Liu WC, Hsu CM. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-_ signaling. Shock 30: 563-570, 2008.
16. Chiu CJ, McArdle A, Brown R, Scott H, Gurd F. Intestinal mucosal lesion in low-flow states. Arch Surg 101: 478-483, 1970.
17. Deitch EA. Gut lymph and lymphatics: a source of factors leading to organ injury and dysfunction. Ann NY Acad Sci 1207: e103-e111, 2010.
18. Deitch EA. Multiple organ failure: pathology and potential future therapy. Ann Surg 216: 117-134, 1992.
19. Edgerton C, Crispin JC, Moratz CM, Bettelli E, Oukka M, Simovic M, Zacharia A, Egan R, Chen J, Dalle Lucca JJ, Jaung YT, Tsokos GC. IL-17 producing CD4_ T cells mediate accelerated ischemia/reperfusion- induced injury in autoimmunity-prone mice. Clin Immunol 130: 313-321, 2009.
20. Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjyo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298: 1424-1427, 2002.
21. Fagarasan S, Honjyo T. T-independent immune response: new aspects of B cell biology. Science 290: 89-92, 2000.
22. Finke D. Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals. Semin Immunopathol 31: 151-169, 2009.
23. Fleming SD, Anderson J, Wilson F, Shea-Donohue T, Tsokos GC. C5 is required for CD49d expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion. Clin Immunol 106: 55-64, 2003.
24. Fleming SD, Egan RP, Chai C, Girardi G, Holters VM, Salmon J, Monestier M, Tsokos GC. Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1 deficient mice. J Immunol 173: 7055-7061, 2004.
25. Fleming SD, Monestier M, Tsokos GC. Accelerated ischemia/reperfusion- induced injury in autoimmunity-prone mice. J Immunol 173: 4230-4235, 2004.
26. Fleming SD, Shea-Donohue T, Guthredge JM, Kulik L, Waldschmidt TJ, Gipson MG, Tsokos GC, Holers VM. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169: 2126-2133, 2002.
27. Fleming SD, Tsokos GC. Complement, natural antibodies, autoantibodies and tissue injury. Autoimmun Rev 5: 89-92, 2006.
28. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost 97: 738-747, 2007.
29. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazanian SK, Ito S, Glickman JN, Glimcher LH. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131: 33-45, 2007.
30. Gibbs SAL, Weiser MR, Kobzik L, Valeri CR, Shepro D, Hechtman HB. P-selectin mediates intestinal ischemic injury by enhancing complement deposition. Surgery 119: 652-656, 1996.
31. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol Gastrointest Liver Physiol 251: G567-G574, 1986.
32. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 28: 623-667, 2010.
33. Hill J, Lindsay TF, Ortiz F, Yeh CG, Hechtman HB, Moor FD Jr. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 149: 1723-1728, 1992.
34. Iapichino G, Callegari ML, Marzorati S, Cigada M, Corbella D, Ferrari S, Morelli L. Impact of antibiotics on the gut microbiota of critically ill patients. J Med Microbiol 57: 1007-1014, 2008.
35. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384, 2010.
36. Keith MP, Moratz C, Egan R, Zacharia A, Greidinger EL, Hoffman RW, Tsokos GC. Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1-/- mice. Autoimmunity 40: 208-216, 2007.
37. Kulik L, Fleming SD, Moratz C, Reuter JW, Novikov A, Chen K, Andrews KA, Markaryan A, Quigg RJ, Silverman GJ, Tsokos GC, Holters VM. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J Immunol 182: 5363-5373, 2009.
38. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 108: 4615-4622, 2011.
39. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102: 11070-11075, 2005.
40. Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 1: 11-22, 2008.
41. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Franguel L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-211, 2006.
42. Matzinger P. The danger model: a renewed sense of self. Science 296: 301-305, 2002.
43. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453: 620-625, 2008.
44. Moses T, Wagner L, Fleming SD. TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage. J Leukoc Biol 86: 971-980, 2009.
45. Osman M, Russel J, Granger DN. Lymphocyte-derived interferon-_ mediates ischemia-reperfusion-induced leukocyte and platelet adhesion in intestinal microcirculation. Am J Physiol Gastrointest Liver Physiol 296: G659-G663, 2009.
46. Pamuk ON, Lapchak PH, Rani P, Pine P, Dalle Luca JJ, Tsokos GC. Spleen tyrosine kinase inhibition prevents tissue damage after ischemia reperfusion. Am J Physiol Gastrointest Liver Physiol 299: G391-G399, 2010.
47. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, Adams H, van Ree R, Stobberingh EE. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56: 661-667, 2007.
48. Pope MR, Hoffman SM, Tomlinson S, Fleming SD. Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Mol Immunol 48: 356-364, 2010.
49. Rakoff-Nahoum A, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 119: 229-241, 2004.
50. Reikvam DH, Erofeev A, Sandvik A, Grcic V, Jahnsen FL, Gaustad P, McCoy KD, Macpherson AJ, Meza-Zepeda LA, Johansen FE. Depletion of murine intestinal microbiota: Effects on gut mucosa and epithelial gene expression. PLos One 6: e17996, 2011.
51. Rifai A, Small PA, Teague PO, Ayoub EM. Experimental IgA nephropathy. J Exp Med 150: 1161-1173, 1979.
52. Schaedler RW, Dubos R, Costello R. Association of germfree mice with bacteria isolated from normal mice. J Exp Med 122: 77-83, 1965.
53. Sellon RK, Tonkonogy S, Shultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224-5231, 1998.
54. Shigematsu T, Wolf RE, Granger DN. T-lymphocytes modulate the microvascular and inflammatory responses to intestinal ischemia-reperfusion. Microcirculation 9: 99-109, 2002.
55. Shimizu K, Ogura H, Hamasaki T, Goto M, Tasaki O, Asahara T, Nomoto K, Morotomi M, Matsushima A, Kuwagata Y, Sugimoto H. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci 56: 1171-1177, 2011.
56. Shuctz M, Tonkonogy SL, Sellon RK, Veltkamp C, Godfrey VL, Kwon J, Grenther WB, Balish E, Horak I, Sartor RB. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 276: G1461-G1472, 1999.
57. Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 19: 59-69, 2007.
58. Sorkine P, Szold O, Halpern P, Gutman M, Greemland M, Rudick V, Goldman G. Gut decontamination reduces bowel ischemia-induced lung injury in rats. Chest 112: 491-495, 1997.
59. Souza DG, Vieira AT, Soares AC, Pinho V, Nicoli JR, Vieira LQ, Teixeira MM. The essential role of the intestinal microbiota in facilitating acute inflammation responses. J Immunol 173: 4137-4146, 2004.
60. Tatum PM, Harmon CM, Lorenz RG, Dimmitt RA. Toll-like receptor 4 is protective against neonatal murine ischemia-reperfusion intestinal injury. J Ped Surg 45: 1246-1255, 2010.
61. Umesaki Y, Setoyama H. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect 2: 1343-1351, 2000.
62. van Saene HK, Taylor N, Donnell SC, Glynn J, Magnall VL, Okada Y, Klein NJ, Pierro A, Lloyd DA. Gut overgrowth with abnormal flora: the missing link in parenteral nutrition-related sepsis in surgical neonates. Eur J Clin Nutr 57: 548-553, 2003.
63. Victoni T, Coelho FR, Soares AL, de Freitas A, Secher T, Guabiraba R, Erard F, de Oliveira-Filho RM, Vargaftg BB, Lauvaux G, Kamal MA, Ryffel B, Moser R, Tavares-de-Lima W. Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/ MyD88 signaling. Med Microbiol Immunol (Berl) 199: 35-42, 2010.
64. Warson MJ, Ke B, Shen XD, Gao F, Busuttil RW, Kupiec-Weglinski JW, Farmer DG. Intestinal ischemia/reperfusion injury triggers activation of innate Toll-like receptor 4 and adaptive chemokine programs. Transplant Proc 40: 3339-3341, 2008.
65. Weeks C, Moratz C, Zacharia A, Stracener C, Egan R, Peckham R, Moore FD Jr, Tsokos GC. Decay-accelerating factor attenuates remote ischemia-reperfusion-initiated organ damage. Clin Immunol 124: 311-327, 2007.
66. Wen L, Ley RE, VOlchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1114, 2008.
67. Williams JP, Pechet TT, Weiser MR, Reid R, Kobzik L, Moore FD Jr, Caroll MC, Hechtman HB. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 86: 938-942, 1999.
68. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, Littman DR, Benoist C, Mathis D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32: 815-827, 2010.
69. Zhang M, Alicot EM, Chiu I, Li Jinan Verna N, Vorup-Jensen T, Kessler B, Shimaoka M, Chan R, Friend D, Mahmood U, Weissleder R, Moore FD, Carroll MC. Identification of the target self-antigens in reperfusion injury. J Exp Med 203: 141-152, 2006.
70. Zhang M, Austen WG Jr, Chiu I, Alicot EM, Hung R, Ma M, Verna N, Xu M, Hechtman HB, Moore FD Jr, Carroll MC. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/ reperfusion injury. Proc Natl Acad Sci USA 101: 3886-3891, 2004.
71. Zhang M, Carroll MC. Natural antibody mediated innate autoimmune response. Mol Immunol 44: 103-110, 2007.
72. Zipris D. Epidemiology of type 1 diabetes and what animal models teach us bout the role of viruses in disease mechanisms. Clin Immunol 131: 11-23, 2009.